echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Clinical Infectious Disease: The relationship between the number of intravenous anti-pseudomonas antibiotics and the clinical outcome of cystic fibrosis in children

    Clinical Infectious Disease: The relationship between the number of intravenous anti-pseudomonas antibiotics and the clinical outcome of cystic fibrosis in children

    • Last Update: 2021-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    The incidence of exacerbated lung disease (PEx) in patients with cystic fibrosis (PwCF) has increased significantly, and the quality of life of these patients will be significantly reduced, and lung function and weight will also be reduced


     


     


     


    This study confirmed that the use of 2 IV anti-pseudomonas antibiotics for PEx treatment in young PwCF patients was not associated with greater improvements in measured respiratory and clinical outcomes compared to a single IV anti-pseudomonas antibiotic treatment


     

    Original source:

    Jonathan D Cogen.


    Association Between Number of Intravenous Antipseudomonal Antibiotics and Clinical Outcomes of Pediatric Cystic Fibrosis Pulmonary Exacerbations.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.